The current treatment approach to diabetic retinopathy (DR) emphasizes early detection, aggressive management of risk factors, and timely intervention to prevent vision loss. Tight glycemic control remains foundational, as it significantly reduces the onset and progression of DR by minimizing microvascular damage. Regular ophthalmic screenings, including comprehensive dilated eye examinations, are crucial for early detection of retinal changes. For non-proliferative diabetic retinopathy (NPDR), management focuses on optimizing systemic control of blood pressure and lipids to slow progression. In cases of clinically significant macular edema (CSME), focal/grid laser photocoagulation and intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents have shown efficacy in reducing macular thickening and improving visual acuity. For proliferative diabetic retinopathy (PDR), prompt treatment with pan-retinal photocoagulation (PRP) is essential to reduce neovascularization and prevent complications such as vitreous hemorrhage or tractional retinal detachment. Surgical options like vitrectomy may be necessary in advanced cases. Individualized management plans tailored to the severity and specific characteristics of DR are critical to preserving vision and optimizing outcomes for diabetic patients.